Literature DB >> 17936758

ZIC1 gene expression is controlled by DNA and histone methylation in mesenchymal proliferations.

Rasoul Pourebrahim1, Kim Van Dam, Marijke Bauters, Ivo De Wever, Raf Sciot, Jean-Jacques Cassiman, Sabine Tejpar.   

Abstract

RNA and protein analysis revealed the consistent upregulation of the neural transcription factors ZIC1 and ZIC4 in desmoid tumors and other fibroproliferative disorders. The 5' flanking region of the ZIC1 promoter was unmethylated in desmoid tumor fibroblasts, while a hypermethylated ZIC1 promoter was found in human and mouse cell lines not expressing the gene. In addition, expressing cells showed a H3K4me2 at the ZIC1 promoter, whereas non-expressing cells showed higher levels of H3K9me2 in the same region. To our knowledge, this is the first report describing ZIC1 expression in mesenchymal proliferations and a role for DNA methylation in the control of ZIC1 expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936758     DOI: 10.1016/j.febslet.2007.09.061

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Functional dissection of the paired domain of Pax6 reveals molecular mechanisms of coordinating neurogenesis and proliferation.

Authors:  Tessa Walcher; Qing Xie; Jian Sun; Martin Irmler; Johannes Beckers; Timucin Öztürk; Dierk Niessing; Anastassia Stoykova; Ales Cvekl; Jovica Ninkovic; Magdalena Götz
Journal:  Development       Date:  2013-03       Impact factor: 6.868

2.  Role of ZIC1 methylation in hepatocellular carcinoma and its clinical significance.

Authors:  Yan-Ying Wang; Jian-Xin Jiang; Hong Ma; Jie Han; Zhi-Yang Sun; Zhong-Min Liu; Zeng-Guang Xu
Journal:  Tumour Biol       Date:  2014-04-30

3.  ZIC1 overexpression is oncogenic in liposarcoma.

Authors:  Elliott Brill; Ryan Gobble; Christina Angeles; Mariana Lagos-Quintana; Aimee Crago; Bernadette Laxa; Penelope Decarolis; Lei Zhang; Cristina Antonescu; Nicholas D Socci; Barry S Taylor; Chris Sander; Andrew Koff; Samuel Singer
Journal:  Cancer Res       Date:  2010-08-16       Impact factor: 12.701

4.  RNA Sequencing and Pathway Analysis Identify Important Pathways Involved in Hypertrichosis and Intellectual Disability in Patients with Wiedemann-Steiner Syndrome.

Authors:  Léo Mietton; Nicolas Lebrun; Irina Giurgea; Alice Goldenberg; Benjamin Saintpierre; Juliette Hamroune; Alexandra Afenjar; Pierre Billuart; Thierry Bienvenu
Journal:  Neuromolecular Med       Date:  2018-07-16       Impact factor: 3.843

5.  Clinicopathological significance of increased ZIC1 expression in human endometrial cancer.

Authors:  Xing Gu; Qin Liu; Ning Yang; Jian-Fang Shen; Xue-Gang Zhang; Fang Cao; Hou-Zhong Ding
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-12-16

6.  ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer.

Authors:  Lihong Gan; Shujie Chen; Jing Zhong; Xian Wang; Emily K Y Lam; Xin Liu; Jianbin Zhang; Tianhua Zhou; Jun Yu; Jianmin Si; Liangjing Wang; Hongchuan Jin
Journal:  PLoS One       Date:  2011-02-15       Impact factor: 3.240

7.  Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia.

Authors:  Xueqin Chen; Zhenghua Lin; Meng Xue; Jianmin Si; Shujie Chen
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

8.  ZIC1 modulates cell-cycle distributions and cell migration through regulation of sonic hedgehog, PI(3)K and MAPK signaling pathways in gastric cancer.

Authors:  Jing Zhong; Shujie Chen; Meng Xue; Qin Du; Jianting Cai; Hongchuan Jin; Jianmin Si; Liangjing Wang
Journal:  BMC Cancer       Date:  2012-07-16       Impact factor: 4.430

9.  NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.

Authors:  Vladimir Kashuba; Alexey A Dmitriev; George S Krasnov; Tatiana Pavlova; Ilya Ignatjev; Vasily V Gordiyuk; Anna V Gerashchenko; Eleonora A Braga; Surya P Yenamandra; Michael Lerman; Vera N Senchenko; Eugene Zabarovsky
Journal:  Int J Mol Sci       Date:  2012-10-18       Impact factor: 5.923

10.  3-M syndrome: a growth disorder associated with IGF2 silencing.

Authors:  P G Murray; D Hanson; T Coulson; A Stevens; A Whatmore; R L Poole; D J Mackay; G C M Black; P E Clayton
Journal:  Endocr Connect       Date:  2013-11-11       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.